Association Between Helicobacter pylori and Gastrointestinal Symptoms in Children abstract OBJECTIVE: Recurrent abdominal pain (RAP) and other gastrointestinal (GI) symptoms are common complaints among children. The role of Helicobacter pylori in the cause of these complaints remains controversial. Nevertheless, there is an increasing pressure on primary care clinicians to screen for H pylori infection in symptomatic children. We systematically reviewed the published evidence for an association between H pylori infection and GI symptoms in children.
Helicobacter pylori is 1 of the most common bacterial pathogens in humans and affects ϳ50% of the world's population. 1 The prevalence of H pylori infection varies greatly between developing countries and developed countries (respectively, 90% vs 40% at the age of 40), 1 and infection is mainly acquired in early childhood. 2 In adults, H pylori infection is associated with conditions such as chronic active gastritis and peptic ulcer disease, 1 and H pylori has been confirmed as the most important risk factor for noncardia gastric adenocarcinomas and gastric mucosa-associated lymphoid tissue lymphomas. 3 Despite this knowledge, the natural history of H pylori infection in children, such as the mode of acquisition and signs of infection, is poorly understood.
Guidelines on screening for H pylori in children contradict. Recommendations vary from no need to screen children with gastrointestinal (GI) symptoms 4 and no need to screen children with recurrent abdominal pain (RAP) 5 to all children with upper GI symptoms should be tested for H pylori infection (Maastricht III). 6 These recommendations are based on the lack of proof that infection with H pylori is a significant cause of GI symptoms.
In addition, nowadays, a lot of diagnostic tests for H pylori are available. Some of them, such as the 13C-urea breath test, detection of H pylori antigen in stool, and detection of specific antibodies in serum, 7 are suitable for use in primary care. Thus, this increased availability is likely to result in increased number of children to be tested. This emphasizes the need for up-to-date guidelines with indications for investigating and treating children for H pylori infection.
Good-quality studies, preferably summarized in a systematic review, form the basis for evidence-based screening guidelines. Previous reviews 8, 9 regarding this topic were limited to the association between H pylori and specific symptoms, such as RAP. Because of the limitations of previous systematic reviews and the several studies published after the publication of these analyses, we performed a new systematic literature review to review systematically the extent and the quality of the current published evidence for a relationship between GI symptoms and H pylori infection in children.
METHODS
To identify relevant publications, we performed a Medline database search from 1966 to July 27, 2009 , by using the following key words: "Helicobacter pylori," "Campylobacter pylori," "abdominal pain," and "dyspepsia." A search strategy for follow-up studies recommended by Altman 10 was added. The Embase database was searched from 1980 to July 27, 2009 ; the search strategy for Medline was adapted for Embase with the assistance of a librarian (Appendix 1). To identify additional potentially relevant publications, we hand searched the reference lists of included studies, of published review articles, and of articles written by experts in the field. No language restriction was used.
Study Selection
We limited our search to studies that compared children who did have symptoms with children who did not have symptoms. All abstracts of identified articles were screened for eligibility, and decisions regarding inclusion of studies were made independently by 2 reviewers (L.A.A.S. and M.B.M. or Y.vL.). We used 4 criteria to select relevant studies: (1) the study had a case-control, cross-sectional, or prospective cohort design; (2) 1 of its aims was to evaluate the association between H pylori infection and GI symptoms; (3) the study group included children aged 0 to 18 years; and (4) at least 30 children were included and separately analyzed. Because of an increased risk for acquiring an H pylori infection, studies concerning exclusively children with relevant comorbidity such as mental disabilities, immunodeficient disorders, and diabetes were excluded.
Interobserver reliability of the eligibility screening was calculated with Cohen's . 11 Any disagreements between both reviewers were resolved through consensus or by arbitration of a third person (M.B.M. or Y.vL.). Full-text articles of all selected titles were retrieved or in case the abstract gave insufficient information on the inclusion criteria. When an included study or the data of a study were not available, first authors were contacted.
Quality Assessment
To rate the risk for bias of the included studies, we scored 9 identical methodologic criteria with 1 additional criterion for case-control/cross-sectional studies and 2 additional criteria for prospective cohort studies (Appendix 2). The criteria were adapted from Altman, 10 Lievense et al, 12 Hayden et al, 13 and the STROBE Statement 14 and were modified to cover the topic of this review. Criteria could be answered with "yes (ϩ)," "no (Ϫ)." or "don't know (?)." One point was given to a criterion answered with "yes," and no points were given when answered with "no" or "don't know." Equal weights were applied to all items, resulting in a maximum score of 10 points for casecontrol/cross-sectional studies and 11 points for prospective cohort studies. Low risk for bias was defined as a score of Ն7 points. Two reviewers scored all included articles independently (L.A.A.S. and M.B.M.). Interobserver variability was calculated with Cohen's . In case of disagreement between both reviewers, a third reviewer (Y.vL.) made the final decision.
Data Extraction and Analysis
Two reviewers performed data extraction on a structured list independently. Extracted data included demographics, description of the study population, inclusion and exclusion criteria, baseline characteristics, type of symptoms analyzed, diagnostic tests used, and outcome data. As a measure for the association between GI symptoms and H pylori, odds ratios (ORs) with 95% confidence intervals (CIs) were calculated for each symptom on the basis of unadjusted data presented in individual studies.
Data analysis was performed by using Review Manager 5.0 (RevMan). The weight given to each study was based on the inverse of the variance. Heterogeneity was quantified by Z 2 and I 2 , which can be interpreted as the percentage of the total variation between studies that is attributable to heterogeneity rather than to chance. A value of 0% indicates no heterogeneity. When statistically significant heterogeneity (P Ͻ .05) was observed, the results of the random-effects model are presented. When there was statistically significant heterogeneity in outcomes across studies, subgroup analyses according to the level of risk for bias and different geographic locations (ie, low-prevalence areas [Western countries, United States, Canada] versus high-prevalence areas [Mediterranean, African, and Asian countries]) were performed. In addition, the effect of outliers on the results was evaluated.
When in studies the term RAP was used, we considered it conform Apley's criteria, 15 when there was a reference to Apley or the definition used by the authors was almost similar in time spectrum to the definition proposed by Apley (ie, at least 3 discrete episodes of abdominal pain of sufficient severity to interrupt normal daily activities or performance over a period of not less than 3 months). When studies reported on "unspecified abdominal pain," "abdominal pain," "symptomatic patients," or "GI-referral patients" in relation to H pylori infection and thus not fulfilling Apley's criteria, we grouped these outcomes as unspecified abdominal pain (UAP).
RESULTS
In total, 1120 potentially relevant abstracts were identified. After removing duplicates, we were left with 880 unique abstracts. After screening all abstracts, 39 publications met our inclusion criteria and none of the exclusion criteria. By searching the reference lists of previous review articles and included studies, we identified 1 additional study. 55 The interobserver agreement of the overall eligibility was ϭ 0.826.
One study could not be retrieved and thus could not be included in our analysis. 49 After reading full-text articles, we excluded another article because the study population did not include children who were aged 0 to 18 years. 50 Finally, 38 articles were reviewed: 23 case-control studies, [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] 53, 54 14 crosssectional studies, 36-47,51,52 and 1 prospective cohort study. 48 Of 23 included case-control studies, 19 were hospital based 16, 17, [19] [20] [21] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] 55 , 3 were population-based, 18, 53, 54 and 1 was primary care based. 22 All crosssectional studies were population based, [36] [37] [38] [39] [40] [41] [42] [44] [45] [46] [47] 51, 55 except for 1 that included children in whom infection was successfully eradicated previously. 43 The only included prospective cohort study was population based. 48
Results of the Methodologic Quality Assessment
The 2 reviewers (L.A.A.S. and M.B.M.) initially agreed on 89.5% of all quality items scored. The interobserver agreement of the assessment of risk for bias was high ( ϭ 0.789).
Mean score of risk for bias of all 38 included studies was 6.03, ranging from 3.00 to 10.00. The mean quality score of case-control studies and cross-sectional studies separately was 5.35 (range: 3.00 -10.00) vs 6.93 (range: 5.00 -9.00), respectively. This difference was mainly caused by the lack of equal assessment of GI symptoms for both case patients and control subjects in 19 of 23 case-control studies, whereas all 14 cross-sectional studies used equal symptom assessment. Furthermore, 12 case-control studies did not draw case patients and control subjects from a population at the same risk for exposure, whereas the studied populations of all crosssectional studies did. The only prospective cohort study scored 9 of 11 points.
In total 8 case-control studies, [17] [18] [19] 22, 28, 29, 30, 53 7 cross-sectional studies, 36, 37, 39, 41, 45, 46, 52 and the prospective cohort study 48 were categorized as having low risk for bias. The most prevalent shortcomings of case-control and cross-sectional studies were a lack of blinded assessment of GI symptoms and H pylori infection (n ϭ 31), no use of multivariate analysis (n ϭ 27), and that prognostic factors were not comparable at baseline and no correction for these factors was applied in the analysis (n ϭ 29).
Prevalence of H pylori
The prevalence of H pylori in populationbased cross-sectional studies ranged from 9.4% to 56.6% with a mean prevalence of 28.0% (SD: 16.2%). The prevalence in high-prevalence areas (n ϭ 8) ranged from 15.8% 47 to 56.6% 36 with a mean prevalence of 37.0%. The prevalence in low-prevalence areas (n ϭ 6) ranged from 9.4% 41 to 28.9%, 42 with a mean prevalence of 16.1%. The effect of different tests on the prevalence of H pylori could not be evaluated because a large diversity of (combinations of) diagnostic tests for H pylori with different cutoff points were used, although the vast majority of studies included serology testing.
RAP and H pylori
Fourteen case-control studies, involving 3253 participants, reported on the relationship between RAP and H pylori infection in children.* Six had low risk for bias 17, 18, 22, 26, 30, 53 and 8 had high risk for bias. 23, 25, [31] [32] [33] [34] 54, 55 Figure 1 presents the meta-analysis of the OR of an H pylori infection given the presence of RAP. Because of statistically significant heterogeneity (P Ͻ .00001), the random-effects model is presented. The pooled OR for all case-control studies was 1.69 (95% CI: 0.99 -2.86).
When we excluded the 2 outlier studies of Mendez Nieto et al 32 and Mukherjee et al. 34 the pooled OR became 1.21 (95% CI: 0.82-1.78), but statistical heterogeneity remained significant. In all additional analyses, the aforementioned outliers remained excluded. Evaluation of heterogeneity explained some of it but did not alter the estimated effect size.
Ten cross-sectional studies, involving 3980 participants, reported on the relation between RAP and H pylori. Four had low risk for bias 36, 37, 39, 45 and 6 high risk. 38, [42] [43] [44] 47, 51 However, the study of Ertem et al, 44 reporting an OR of 1.33, could not be pooled due to missing the pooled OR for the remaining studies was 1.69 (95% CI: 0.83-3.44; random effects-model; P Ͻ .00001; Fig 2) . The studies of Leandro Liberato et al 47 and Telmesani 51 explained statistical heterogeneity; excluding these outliers resulted in a pooled OR of 1.00 (95% CI: 0.76 -1.31; fixed model; P ϭ .60). In additional analyses, these outliers remained excluded.
The pooled OR for the 4 studies with low risk for bias was 0.95 (95% CI: 0.66 -1.37; fixed model; P ϭ .24). The relationship between RAP and H pylori infection was not influenced by risk for bias, setting, or geographic location. Two case-control studies 22,30 and 2 cross-sectional studies 37, 46 concerning RAP reported ORs adjusted for confounders (Tables 1 and 2) ; however, all adjusted ORs are comparable to the pooled unadjusted ORs presented and remained nonsignificant.
UAP and H pylori
Six hospital-based case-control studies 16, 19, 21, 24, 28, 35 that included 3142 participants reported on the association between UAP and H pylori infection. Two studies with low risk for bias 19, 28 and 4 with high risk 16, 21, 24, 35 had a pooled OR of 2.87 (95% CI: 1.62-5.09; random-effects model; P ϭ .0001; Fig 3) . In the studies with low risk for bias only, the pooled OR was 1.66 (95% CI: 1.21-2.28; fixed model; P ϭ .23). Pooling the 4 studies with high risk for bias resulted in a pooled OR of 4.69 (95% CI: 3.35-6.57; fixed model; P ϭ .36).
Five population-based cross-sectional studies 36,37,39,41,52 that included 3251 participants and reported on UAP in children who were seen in primary care all had low risk for bias. The pooled OR was 0.99 (95% CI: 0.46 -2.11; random-effects model; P Ͻ .00001; Fig 4) .
Three studies, 1 hospital-based casecontrol study 16 and 2 population-based cross-sectional studies, 37, 52 adjusted for confounders (Tables 1 and 2 ). The adjusted ORs were comparable to the pooled ORs presented.
Epigastric Pain and H pylori
Epigastric pain was evaluated in 2 case-control studies 18, 20 and 1 crosssectional study. 43 Because of the diversity of outcome definitions, we were not able to pool data. The populationbased case-control study of Yang et al 18 
FIGURE 1
Meta-analysis of case-control studies concerning RAP related to H pylori infection. Events indicates number children with H pylori infection.
253 participants. They reported on short-term recurrent abdominal pain (SRAP): abdominal pain that met Apley's criteria 15 but with a shorter duration in a range from 2 weeks to 3 months. The prevalence of H pylori infection was higher in children with SRAP than in healthy control subjects (OR: 3.4 [95% CI: 1.6 -7.2]). They further assessed whether specific clinical presentations were associated with H pylori infection in the children with SRAP or RAP. Children who presented with abdominal pain in the epigastric area had a significantly higher prevalence of H pylori infection when they had SRAP but not when they had RAP; the OR could not be calculated with the available data.
The hospital-based case-control study of Ng et al 20 had high risk for bias. The study, which included 1088 participants, reported an OR of 2.03 (95% CI: 1.35-3.06) given the presence of epigastric pain. The OR of the 1 hospital-based cross-sectional study with high risk for bias 43 was 3.2 (95% CI: 0.77-13.35).
Diarrhea and H pylori
Two case-control studies 18,27 and 3 population-based cross-sectional studies 36, 39, 40 reported outcomes on the association between diarrhea and H pylori infection in children. One casecontrol study 18 and 2 cross-sectional studies 36, 39 had low risk for bias. All studies that reported on diarrhea, except for the 1 by Bode et al, 39 were performed in high-prevalence areas. The pooled OR in case-control studies that included 365 participants, 1 of which was population based 18 and 1 of which was hospital based, 27 was 0.95 (95% CI: 0.47-1.90; fixed model; P ϭ .32). In the cross-sectional studies that included 999 participants, the pooled OR was 0.70 (95% CI: 0.13-3.96; random-effects model; P ϭ .01).
Vomiting and H pylori
Three population-based cross-sectional studies, all of which were at low risk for bias, included 2054 participants and investigated the association between vomiting and H pylori infection 36, 39, 52 ; the pooled OR was 1.05 (95% CI: 0.40 -2.75; random-effects model; P ϭ .0002). Two studies 36, 52 were performed in high-prevalence areas, and 1 study 39 was performed in lowprevalence areas.
Other Symptoms and H pylori
Several studies reported on various other GI symptoms, such as periumbilical pain, 18 flatus, 18 constipation, 18, 37 nausea, 43 loose stools, 37 postprandial fullness, 18, 43 halitosis, 43 dyspepsia, 29, 36 and regurgitation, 37 but none of these symptoms was associated with H pylori infection.
The only prospective cohort study with a follow-up period from 6 months to 11 years 48 included 305 participants and had low risk for bias. The authors concluded that UAP during childhood was reported more often in children with H pylori seropositivity at some point during the study than for seronegative children (adjusted OR: 2.2 [95% CI: 1.0 -4.4). Children who were seropositive at some point during the study more often reported RAP at 11 years of age than did seronegative children, but the difference was not statistically significant (OR adjusted for gender: 2.0 [95% CI: 0.8 -4.6) ( Table 3) . Spontaneous clearance of H pylori infection was reported in 80% of previously infected children at the end of the study.
DISCUSSION
We found evidence for an association between UAP (ie, patients with abdominal pain, symptoms, or GI referral) and H pylori infection in referred children (pooled OR: 2.87 [95% CI: 1.62-5.09) but could not confirm this finding in children who were seen in primary care (pooled OR: 0.99 [95% CI: 0.46 -2.11). Two studies 16, 37 adjusted for known risk factors for H pylori, but this did not change this results. In addition, we found conflicting evidence for an The finding for an association between UAP and H pylori infection in referred children but not in children who were seen in primary care is in agreement with our finding of evidence that RAP and H pylori are not related. Abdominal pain in a child who sees a general practitioner (GP) has a different differential diagnosis than abdominal pain in a child who is seen in secondary care. Abdominal pain in primary care more often will be functional. In a setting where a symptom is dominantly related to functional disease, an association between the symptom and a low-prevalent disorder might be too weak to detect. In addition, a GP will
FIGURE 3
Meta-analysis of case-control studies concerning UAP related to H pylori infection. Events indicates number children with H pylori infection.
FIGURE 4
Meta-analysis of cross-sectional studies concerning UAP related to H pylori infection. Events indicates number children with H pylori infection. RAP is mainly defined by the duration of abdominal pain. We assume that selecting children with RAP is more than a selection that is based on duration of abdominal pain alone. Selection of children with RAP will implicitly comprise the belief of the primary care clinician that RAP in the long-term does not affect growth and that development of the child will be functional and that in referred children it will comprise the (negative) results of previous investigations. Because of these implicit selection criteria, we assume that the included children with RAP will be at high risk for functional disease. None of these selection mechanisms, however, was described in the studies on RAP that were included in this review. That duration of pain may preclude underlying disorders as a result of the aforementioned mechanisms is affirmed by the findings of Yang et al. 18 That population-based study reported a statistically significant association between SRAP (ie, abdominal pain that met the criteria of Apley and Naish 15 but with a shorter duration in range from 2 weeks to 3 months) in the epigastric region and H pylori infection.
To our knowledge, this is the first published review to investigate the association between GI symptoms in general and H pylori infection in children. The results of our review concerning RAP are consistent with 2 previous systematic reviews that reported no obvious association between RAP and H pylori infection in children. 8, 9 Although our literature search was comprehensive, some published and unpublished studies may have been missed. Also, some information pertinent to the review and collected by the reviewers may not have been provided in the journal article, although we contacted first authors to request missing data with variable success.
Cautious interpretation of pooled ORs is necessary because we found a large statistical and clinical heterogeneity between studies and an overall poor methodologic quality. Using a best evidence synthesis to summarize the data could overcome these problems, but limited data exist on best evidence syntheses for observational studies, and the possibility of misclassifying the results of studies with a small sample size is large.
We found that children who are referred to a gastroenterologist with UAP or pain in the epigastric region in general are at two-to threefold higher risk for H pylori infection than children without these symptoms. Because we are not aware of the criteria on which a GP decides to refer a child with abdominal pain to a pediatric gastroenterologist, a more specific clinical picture has yet to be established. Whether to screen systematically referred children with abdominal (epigastric) pain depends on effectiveness and adverse effects of eradication therapy. No optimal treatment has yet been defined.
To confirm, disclaim, or specify our findings on UAP and epigastric pain, additional research is necessary. If there is an association between these symptoms and H pylori infection, then treating and thus eradicating H pylori must lead to improvement or disappearance of symptoms. Randomized, placebo-controlled, double-blind trials with minimal loss to follow-up and standardized and validated outcome measures are needed. To our knowledge, no such trial has been published.
CONCLUSIONS
There is no association between RAP and H pylori infection in children; therefore, screening children with this classical symptom is not warranted, regardless of setting and geographic location. Furthermore, all other GI symptoms investigated in primary care-based or population-based studies, except for epigastric pain, were not associated with H (('epidemiologic studies'/exp OR 'epidemiologic studies') OR 'cross-sectional study' OR 'case control study' OR 'cohort analysis' OR ('follow up'/exp OR 'follow up') OR longitudinal OR prospective OR retrospective) AND (('helicobacter pylori'/exp OR 'helicobacter pylori') OR ('campylobacter'/exp OR 'campylobacter')) AND (('gastrointestinal symptom'/exp OR 'signs and symptoms, digestive') OR ('abdominal pain'/exp OR 'abdominal pain') OR ('dyspepsia'/exp OR 'dyspepsia')) AND (('infant'/exp OR 'infant') OR infant* OR ('child'/exp OR 'child') OR child* OR ('adolescent'/exp OR 'adolescent') OR adolescen*)
